• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

婴幼儿对肺炎球菌结合疫苗的免疫反应与疫苗实施后的间接保护之间的关系。

Relationship between immune response to pneumococcal conjugate vaccines in infants and indirect protection after vaccine implementation.

机构信息

a The Faculty of Health Sciences , Ben-Gurion University of the Negev , Beer-Sheva , Israel.

出版信息

Expert Rev Vaccines. 2019 Jun;18(6):641-661. doi: 10.1080/14760584.2019.1627207. Epub 2019 Jun 22.

DOI:10.1080/14760584.2019.1627207
PMID:31230486
Abstract

: is a leading cause of morbidity and mortality worldwide. Widespread infant vaccination with pneumococcal conjugate vaccines (PCVs) substantially reduced vaccine-serotype pneumococcal disease by direct protection of immunized children and indirect protection of the community via decreased nasopharyngeal carriage and transmission. Essential to grasping the public health implications of pediatric PCV immunization is an understanding of how PCV formulations impact carriage. : Using clinical evidence, this review examines how the immune response to PCVs is associated with subsequent nasopharyngeal carriage reduction in vaccinated infants and toddlers. By combining direct and indirect protection, carriage reduction results in a reduced spread of vaccine serotypes, and eventually, a decrease in vaccine serotype disease incidence in community members of all ages. : The current review presents some of the aspects that influence the overall impact of PCVs on vaccine-serotype carriage, and thus, spread. The link between reduction of vaccine-serotype carriage and the eventual reduction of vaccine-serotype disease in the wider community is described by comparing data from current PCVs, specifically with respect to their ability to reduce carriage of some cross-reacting serotypes (i.e. 6A versus 6B and 19A versus 19F).

摘要

肺炎是全球发病率和死亡率的主要原因。广泛使用肺炎球菌结合疫苗(PCV)对婴幼儿进行免疫接种,通过减少鼻咽携带和传播,直接保护免疫儿童,间接保护社区人群,大大降低了疫苗血清型肺炎球菌疾病。了解 PCV 疫苗接种对携带情况的影响对于掌握儿科 PCV 免疫接种的公共卫生意义至关重要。本综述利用临床证据,研究了 PCV 制剂对疫苗接种婴儿和幼儿随后鼻咽携带减少的免疫反应如何相关。通过结合直接和间接保护,携带减少导致疫苗血清型传播减少,最终导致所有年龄段社区成员中疫苗血清型疾病发病率降低。本综述介绍了一些影响 PCV 对疫苗血清型携带总体影响的因素,因此,也影响了传播。通过比较当前 PCV 的数据(特别是它们减少某些交叉反应性血清型(即 6A 与 6B 和 19A 与 19F)携带的能力),描述了疫苗血清型携带减少与更广泛社区中疫苗血清型疾病最终减少之间的联系。

相似文献

1
Relationship between immune response to pneumococcal conjugate vaccines in infants and indirect protection after vaccine implementation.婴幼儿对肺炎球菌结合疫苗的免疫反应与疫苗实施后的间接保护之间的关系。
Expert Rev Vaccines. 2019 Jun;18(6):641-661. doi: 10.1080/14760584.2019.1627207. Epub 2019 Jun 22.
2
Streptococcus pneumoniae serotype 19A: worldwide epidemiology.19A 型肺炎链球菌:全球流行病学。
Expert Rev Vaccines. 2017 Oct;16(10):1007-1027. doi: 10.1080/14760584.2017.1362339. Epub 2017 Aug 28.
3
Pneumococcal conjugate vaccine induced IgG and nasopharyngeal carriage of pneumococci: Hyporesponsiveness and immune correlates of protection for carriage.肺炎球菌结合疫苗诱导的IgG及肺炎球菌的鼻咽部携带:低反应性及携带保护的免疫相关因素
Vaccine. 2017 Aug 16;35(35 Pt B):4652-4657. doi: 10.1016/j.vaccine.2017.05.088. Epub 2017 Jul 21.
4
The impact of pneumococcal conjugate vaccines on serotype 19A nasopharyngeal carriage.肺炎球菌结合疫苗对 19A 型鼻咽携带的影响。
Expert Rev Vaccines. 2019 Dec;18(12):1243-1270. doi: 10.1080/14760584.2019.1675521.
5
The impact of routine childhood immunization with higher-valent pneumococcal conjugate vaccines on antimicrobial-resistant pneumococcal diseases and carriage: a systematic literature review.常规儿童接种高价肺炎球菌结合疫苗对耐药性肺炎球菌疾病和携带的影响:系统文献回顾。
Expert Rev Vaccines. 2019 Oct;18(10):1069-1089. doi: 10.1080/14760584.2019.1676155. Epub 2019 Oct 22.
6
Pneumococcal nasopharyngeal carriage in children <5 years of age visiting the pediatric emergency room in relation to PCV7 and PCV13 introduction in southern Israel.以色列南部5岁以下儿童在接种7价肺炎球菌结合疫苗(PCV7)和13价肺炎球菌结合疫苗(PCV13)前后,前往儿科急诊室时的肺炎球菌鼻咽携带情况。
Hum Vaccin Immunother. 2016;12(2):268-76. doi: 10.1080/21645515.2015.1095414.
7
The rise and fall of pneumococcal serotypes carried in the PCV era.肺炎球菌结合疫苗(PCV)时代所携带的肺炎球菌血清型的兴衰。
Vaccine. 2017 Mar 1;35(9):1293-1298. doi: 10.1016/j.vaccine.2017.01.035. Epub 2017 Feb 1.
8
Impact of pneumococcal conjugate vaccines on nasopharyngeal carriage and invasive disease among unvaccinated people: review of evidence on indirect effects.肺炎球菌结合疫苗对未接种人群鼻咽携带和侵袭性疾病的影响:间接效应的证据综述。
Vaccine. 2013 Dec 17;32(1):133-45. doi: 10.1016/j.vaccine.2013.05.005. Epub 2013 May 16.
9
Persistent Circulation of Vaccine Serotypes and Serotype Replacement After 5 Years of Infant Immunization With 13-Valent Pneumococcal Conjugate Vaccine in the United Kingdom.英国接种 13 价肺炎球菌结合疫苗 5 年后,疫苗血清型持续循环和血清型替换。
J Infect Dis. 2020 Mar 28;221(8):1361-1370. doi: 10.1093/infdis/jiz178.
10
Colonization with 19F and other pneumococcal conjugate vaccine serotypes in children in St. Louis, Missouri, USA.美国密苏里州圣路易斯市儿童中19F及其他肺炎球菌结合疫苗血清型的定植情况。
Vaccine. 2017 Aug 3;35(34):4389-4395. doi: 10.1016/j.vaccine.2017.06.047. Epub 2017 Jul 4.

引用本文的文献

1
Clinical and evidence-based considerations for choosing a pneumococcal conjugate vaccine in India: A narrative review.印度肺炎球菌结合疫苗选择的临床与循证考量:一篇叙述性综述
Hum Vaccin Immunother. 2025 Dec;21(1):2482285. doi: 10.1080/21645515.2025.2482285. Epub 2025 Apr 3.
2
PCV13-Serotype Breakthrough Pneumococcal Disease in Infants Receiving High-Valency Conjugate Vaccines: Population-Level Modeling in France.接受高价结合疫苗的婴儿中13价肺炎球菌结合疫苗血清型突破肺炎球菌疾病:法国的人群水平建模
Infect Dis Ther. 2025 Apr;14(4):753-764. doi: 10.1007/s40121-025-01123-4. Epub 2025 Mar 19.
3
Microbiological aetiology of paediatric respiratory tract infections in Kyrgyzstan.
吉尔吉斯斯坦小儿呼吸道感染的微生物病因学
BMC Infect Dis. 2025 Feb 26;25(1):280. doi: 10.1186/s12879-025-10668-1.
4
Modelling the Epidemiological Impact of Different Adult Pneumococcal Vaccination Strategies in the United Kingdom.模拟英国不同成人肺炎球菌疫苗接种策略的流行病学影响
Infect Dis Ther. 2025 Mar;14(3):587-602. doi: 10.1007/s40121-025-01111-8. Epub 2025 Feb 11.
5
Synthesis of oligosaccharides from terminal B. pertussis LPS pentasaccharide and definition of the minimal epitope recognized by anti-pertussis antibodies.从百日咳博德特氏菌脂多糖五糖末端合成寡糖,并确定抗百日咳抗体识别的最小表位。
Glycoconj J. 2024 Oct;41(4-5):241-254. doi: 10.1007/s10719-024-10160-z. Epub 2024 Jul 24.
6
Progress in research and development of preventive vaccines for children in China.中国儿童预防性疫苗的研发进展
Front Pediatr. 2024 Jul 3;12:1414177. doi: 10.3389/fped.2024.1414177. eCollection 2024.
7
Immunogenicity of Current and Next-Generation Pneumococcal Conjugate Vaccines in Children: Current Challenges and Upcoming Opportunities.当前及下一代肺炎球菌结合疫苗在儿童中的免疫原性:当前挑战与未来机遇
Open Forum Infect Dis. 2024 May 6;11(5):ofae220. doi: 10.1093/ofid/ofae220. eCollection 2024 May.
8
What Works for Controlling Meningitis Outbreaks: A Case Study from China.控制脑膜炎疫情的有效方法:来自中国的案例研究
Vaccines (Basel). 2023 Nov 27;11(12):1762. doi: 10.3390/vaccines11121762.
9
A randomized, open-label, phase 3 study evaluating safety and immunogenicity of 13-valent pneumococcal conjugate vaccine in Chinese infants and children under 6 years of age.一项评价 13 价肺炎球菌结合疫苗在中国 6 岁以下婴幼儿中的安全性和免疫原性的随机、开放标签、3 期研究。
Hum Vaccin Immunother. 2023 Aug 1;19(2):2235926. doi: 10.1080/21645515.2023.2235926.
10
The impact of introduction of the 10-valent pneumococcal conjugate vaccine on pneumococcal carriage in Nigeria.10 价肺炎球菌结合疫苗引入对尼日利亚肺炎球菌带菌率的影响。
Nat Commun. 2023 May 9;14(1):2666. doi: 10.1038/s41467-023-38277-z.